ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Integrated chemical profiling, network pharmacology and pharmacological evaluation to explore the potential mechanism of Xinbao pill against myocardial ischaemia-reperfusion injury

Yang, Ying; Chen, Ting; Liu, Jiaming; Chen, Sixuan; Cai, Rongqing; Wu, Liqiong; Hu, Jiexiong; Lin, Qiongying; Qi, Xiaoxiao; Liu, Zhongqiu*; Cheng, Yuanyuan*广东药学院; 广州中医药大学
PHARMACEUTICAL BIOLOGY2022-12-31DOI: 10.1080/13880209.2022.2025859
5被引9阅读
引用收藏
分享

摘要

Context Xinbao pill (XBW), a traditional Chinese herbal formula, is widely used in clinical treatment for cardiovascular diseases; however, the therapeutic effect of XBW on myocardial ischaemia-reperfusion injury (MI/RI) is unclear. Objective This study evaluates the cardioprotective effect and molecular mechanism of XBW against MI/RI. Materials and methods A phytochemistry-based network pharmacology analysis was used to uncover the mechanism of XBW against MI/RI. Ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry method was used to identify chemicals. MI/RI-related targets of XBW were predicted using TargetNet database, OMIC database, etc. Sprague-Dawley (SD) rats under anterior descending artery ligation model were divided into Sham, MI/RI and XBW (180 mg/kg, intragastric administration). After 30 min ischaemia and 24 h reperfusion, heart tissues were collected for measurement of myocardial infarct size. After oxygen glucose deprivation for 6 h, H9c2 cells were treated with XBW (60, 240 and 720 mu g/mL) and diazoxide (100 mu M) for 18 h of reperfusion. Results Thirty-seven chemicals were identified in XBW; 50 MI/RI-related targets of XBW were predicted using indicated databases. XBW significantly reduced infarct size and creatine kinase MB (CK-MB) level after MI/RI; XBW protected H9c2 cells against OGD/R injury. Gene ontology (GO) and KEGG pathway enrichment analyses by String database showed that the cardioprotective effect of XBW was associated with autophagy and apoptosis signalling pathways. Experimental investigation also verified that XBW suppressed apoptosis, autophagy and endoplasmic reticulum (ER) stress. Conclusions XBW showed therapeutic effects against MI/RI mainly via attenuating apoptosis though suppressing excessive autophagy and ER stress.

学科与关键词

关键词
UHPLC-QTOF-MSchemical profileautophagyER stress
相关
加载中…
  • Integrating network analysis and experimental validation to reveal the mitophagy-associated mechanism of Yiqi Huoxue (YQHX) prescription in the treatment of myocardial ischemia/reperfusion injury
    Chen, Mingtai*; Zhong, Guofu; Liu, Mengnan; Zhou, Jie; Chen, Jianping; Zhang, Mingsheng; Liu, Qiang; Tong, Guangdong; Luan, Jienan*; Zhou, Hua*; He, HaoPharmacological Research, 2023, 189: 106682.被引 5
  • Huoxin Pill Reduces Myocardial Ischemia Reperfusion Injury in Rats via TLR4/NFκB/NLRP3 Signaling Pathway
    Cao, Ce; Qi, Yu-tong; Wang, Ao-ao; Wang, Zi-yan; Liu, Zi-xin; Meng, Hong-xu; Li, Lei; Liu, Jian-xun*Chinese Journal of Integrative Medicine, 2023, 29(12): 1066-1076.被引 1
  • Protective effect of Qingre Huoxue decoction against myocardial infarction via PI3K/Akt autophagy pathway based on UPLC-MS, network pharmacology, and in vivo evidence
    Jin, Zheng; Zhang, Wenbo; Luo, Yuan; Li, Xiushen; Qing, Lijin; Zuo, Qiang; Fang, Junfeng*; Wu, Wei*PHARMACEUTICAL BIOLOGY, 2021, 59(1): 1607-1618.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
PHARMACEUTICAL BIOLOGY
发表日期
2022-12-31
卷期
第 60 卷, 第 1 期
页码
255-273
DOI
10.1080/13880209.2022.2025859
语言
ENGLISH
期刊等级
3区
成果收录
SCIE
资助标注
Key-Area Research and Development Program of Guangdong Province [2020B1111100004]; Science and Technology Program of Guangzhou [2021-02-01-11-30160014]; National Natural Science Foundation of China [81803765, 82074053]; Natural Science Foundation of Guangdong Province [1914050000567]; Guangdong Key Laboratory for translational Cancer research of Chinese Medicine [2018B030322011]; National Key Research and Development Program of China [2017YFE0119900]; Guangdong Basic and Applied Basic Research Foundation [2020B1515130005]; 2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund (Guangdong-Hong Kong-Macau Joint Lab) [2020B1212030006]

作者

  • Y

    Yang, Ying (第一作者)

    guangzhou univ chinese med

  • C

    Chen, Ting

查看全部 11 位作者收起作者
  • L

    Liu, Jiaming

    guangzhou univ chinese med · guangdong pharmaceut univ

  • C

    Chen, Sixuan

    guangzhou univ chinese med

  • C

    Cai, Rongqing

  • W

    Wu, Liqiong

  • H

    Hu, Jiexiong

  • L

    Lin, Qiongying

  • Q

    Qi, Xiaoxiao

    guangzhou univ chinese med

  • L

    Liu, Zhongqiu (通讯)

    guangzhou univ chinese med

  • C

    Cheng, Yuanyuan (通讯)

    guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417